These results highlighted extracellular matrix 1a, integrin αXβ2, hnRNPLL, and ATP Binding Cassette Subfamily G Member 1 (ABCG1) as potential targets for treating cancers associated with extracellularmatrix1-activated signaling. This evidence concerns the gene ABCG1 and cancer.